These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21240812)

  • 1. Clarifying the dispute over academic-industry relationships.
    Huddle TS
    Am J Bioeth; 2011 Jan; 11(1):47-9. PubMed ID: 21240812
    [No Abstract]   [Full Text] [Related]  

  • 2. Clarifying conflict of interest.
    Brody H
    Am J Bioeth; 2011 Jan; 11(1):23-8. PubMed ID: 21240802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Answering Brody's challenge from a pharmapologist perspective.
    Harter TD
    Am J Bioeth; 2011 Jan; 11(1):29-30. PubMed ID: 21240803
    [No Abstract]   [Full Text] [Related]  

  • 4. Beyond a pejorative understanding of conflict of interest.
    Williams-Jones B
    Am J Bioeth; 2011 Jan; 11(1):1-2. PubMed ID: 21240793
    [No Abstract]   [Full Text] [Related]  

  • 5. Responses to peer commentaries on "Clarifying conflict of interest".
    Brody H
    Am J Bioeth; 2011 Jan; 11(1):W4-5. PubMed ID: 21240796
    [No Abstract]   [Full Text] [Related]  

  • 6. Conflict of interest in the physician interface with the biomedical industry.
    Minnigan H; Chisholm CD
    Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doctors and drug companies: the beauty and the beast?
    Guömundsson S
    Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
    [No Abstract]   [Full Text] [Related]  

  • 8. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
    Quan SF
    J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physicians and the drug industry. "To be like that, you'd better be married."].
    Peiró S
    Rev Calid Asist; 2009 Apr; 24(2):47-50. PubMed ID: 19426926
    [No Abstract]   [Full Text] [Related]  

  • 11. Doctors and drug companies.
    Blumenthal D
    N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
    [No Abstract]   [Full Text] [Related]  

  • 12. No more free lunches: it is time to own up.
    Fitzpatrick C
    BMJ; 2003 Aug; 327(7410):342. PubMed ID: 12907499
    [No Abstract]   [Full Text] [Related]  

  • 13. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industry has undue influence on academic collaboration and safeguards need strengthening: white coat… which hat.
    Harbin T
    Surv Ophthalmol; 2014; 59(3):346-8. PubMed ID: 24508214
    [No Abstract]   [Full Text] [Related]  

  • 15. In defense of industry-physician relationships.
    Nakayama DK
    Am Surg; 2010 Sep; 76(9):987-94. PubMed ID: 20836349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Australian regulator insists on greater transparency of industry payments to doctors.
    Coopes A
    BMJ; 2014 Oct; 349():g6335. PubMed ID: 25331811
    [No Abstract]   [Full Text] [Related]  

  • 17. A review of the federal guidelines that inform and influence relationships between physicians and industry.
    Birkhahn RH; Jauch E; Kramer DA; Nowak RM; Raja AS; Summers RL; Weber JE; Diercks DB;
    Acad Emerg Med; 2009 Aug; 16(8):776-81. PubMed ID: 19594459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distributions of industry payments to Massachusetts physicians.
    Kesselheim AS; Robertson CT; Siri K; Batra P; Franklin JM
    N Engl J Med; 2013 May; 368(22):2049-52. PubMed ID: 23635021
    [No Abstract]   [Full Text] [Related]  

  • 19. The dos and don'ts of collaborating with industry.
    Moynihan R
    BMJ; 2012 May; 344():e3247. PubMed ID: 22569871
    [No Abstract]   [Full Text] [Related]  

  • 20. The ethics of physician-pharmaceutical company relationships.
    Thompson WG
    CMAJ; 1988 Nov; 139(9):835-6. PubMed ID: 3179887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.